Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The anandamide reuptake transporter is a putative molecular entity involved in the facilitated uptake of anandamide, a key endogenous cannabinoid neurotransmitter. It plays a crucial role in terminating anandamide signaling by rapidly removing it from the extracellular space. While pharmacological evidence supports its existence, the precise molecular identity remains unknown. Inhibition of this transporter elevates extracellular anandamide levels, suggesting potential therapeutic applications in various conditions, but further research is needed to address safety concerns and confirm its molecular identity.
Inhibition of anandamide reuptake, leading to elevated extracellular anandamide levels
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anandamide Reuptake Transporter.